Gentel Biosciences, Van Andel Get Patent For Cancer Screening Tool
GRAND RAPIDS - Gentel Biosciences and Van Andel Research Institute announced Friday they have been granted U.S. Patent 7,838,634 for a new screening tool that could will help provide early detection of certain types of cancers. The patent provides for a new method to profile changes in the glycosylation of proteins captured on the surface